197 related articles for article (PubMed ID: 22590494)
1. Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10.
Hansen BF; Glendorf T; Hegelund AC; Lundby A; Lützen A; Slaaby R; Stidsen CE
PLoS One; 2012; 7(5):e34274. PubMed ID: 22590494
[TBL] [Abstract][Full Text] [Related]
2. Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor.
Yehezkel E; Weinstein D; Simon M; Sarfstein R; Laron Z; Werner H
Diabetologia; 2010 Dec; 53(12):2667-75. PubMed ID: 20835859
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.
Eckardt K; May C; Koenen M; Eckel J
Diabetologia; 2007 Dec; 50(12):2534-43. PubMed ID: 17898992
[TBL] [Abstract][Full Text] [Related]
4. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells.
Weinstein D; Simon M; Yehezkel E; Laron Z; Werner H
Diabetes Metab Res Rev; 2009 Jan; 25(1):41-9. PubMed ID: 19145584
[TBL] [Abstract][Full Text] [Related]
5. Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
Lundby A; Bolvig P; Hegelund AC; Hansen BF; Worm J; Lützen A; Billestrup N; Bonnesen C; Oleksiewicz MB
J Appl Toxicol; 2015 Jul; 35(7):842-50. PubMed ID: 25413577
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of insulin glargine and its metabolites during long-term insulin therapy in type 2 diabetic patients and comparison of effects of insulin glargine, its metabolites, IGF-I, and human insulin on insulin and igf-I receptor signaling.
Varewijck AJ; Yki-Järvinen H; Schmidt R; Tennagels N; Janssen JA
Diabetes; 2013 Jul; 62(7):2539-44. PubMed ID: 23569175
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes.
Ma Z; Christiansen JS; Laursen T; Lauritzen T; Frystyk J
Eur J Endocrinol; 2014 Oct; 171(4):471-9. PubMed ID: 25005937
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.
Pierre-Eugene C; Pagesy P; Nguyen TT; Neuillé M; Tschank G; Tennagels N; Hampe C; Issad T
PLoS One; 2012; 7(7):e41992. PubMed ID: 22848683
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
Chisalita SI; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.
Rowzee AM; Ludwig DL; Wood TL
Endocrinology; 2009 Aug; 150(8):3611-9. PubMed ID: 19406949
[TBL] [Abstract][Full Text] [Related]
11. A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.
Baricevic I; Jones DR; Roberts DL; Lutzen A; Lundby A; Worm J; Hansen BF; Renehan AG
Carcinogenesis; 2015 Sep; 36(9):1040-50. PubMed ID: 26026165
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblasts.
Warnken M; Reitzenstein U; Sommer A; Fuhrmann M; Mayer P; Enzmann H; Juergens UR; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):511-24. PubMed ID: 20924562
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Insulin-like Growth Factors Hybrids as Molecular Probes of Hormone:Receptor Binding Specificity.
Křížková K; Chrudinová M; Povalová A; Selicharová I; Collinsová M; Vaněk V; Brzozowski AM; Jiráček J; Žáková L
Biochemistry; 2016 May; 55(21):2903-13. PubMed ID: 27171135
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis.
Svendsen AM; Winge SB; Zimmermann M; Lindvig AB; Warzecha CB; Sajid W; Horne MC; De Meyts P
Biochem J; 2014 Jan; 457(1):69-77. PubMed ID: 24059861
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites.
Sommerfeld MR; Müller G; Tschank G; Seipke G; Habermann P; Kurrle R; Tennagels N
PLoS One; 2010 Mar; 5(3):e9540. PubMed ID: 20209060
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
Chisalita SI; Nitert MD; Arnqvist HJ
Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
[TBL] [Abstract][Full Text] [Related]
17. IGF-I/insulin hybrid receptors in human endothelial cells.
Nitert MD; Chisalita SI; Olsson K; Bornfeldt KE; Arnqvist HJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):31-7. PubMed ID: 15607526
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic potency of insulin glargine.
Zełobowska K; Gumprecht J; Grzeszczak W
Endokrynol Pol; 2009; 60(1):34-9. PubMed ID: 19224503
[TBL] [Abstract][Full Text] [Related]
19. Converting Insulin-like Growth Factors 1 and 2 into High-Affinity Ligands for Insulin Receptor Isoform A by the Introduction of an Evolutionarily Divergent Mutation.
Macháčková K; Chrudinová M; Radosavljević J; Potalitsyn P; Křížková K; Fábry M; Selicharová I; Collinsová M; Brzozowski AM; Žáková L; Jiráček J
Biochemistry; 2018 Apr; 57(16):2373-2382. PubMed ID: 29608283
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin.
Wada T; Azegami M; Sugiyama M; Tsuneki H; Sasaoka T
Diabetes Res Clin Pract; 2008 Sep; 81(3):269-77. PubMed ID: 18585815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
